Trials / Conditions / Adult Onset Still Disease

Adult Onset Still Disease

6 registered clinical trials studyying Adult Onset Still Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients NCT07517250	Novartis Pharmaceuticals	—
Recruiting	Rheumatology Patient Registry and Biorepository NCT04402086	Yale University	—
Unknown	Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population NCT03651193	Second Xiangya Hospital of Central South University	—
Completed	A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic NCT03311854	Swedish Orphan Biovitrum	Phase 2
Completed	Admission of Adult-onset Still Disease Patients in the ICU NCT03276650	Central Hospital, Nancy, France	—
Completed	Evaluation of Adult Onset Still Disease Classification Criteria and Differential Diagnosis at Eighteen Months NCT04750863	Central Hospital, Nancy, France	—